Ambu gets recommendation from FDA, analyst doubts effect
The FDA recommendation that single-use bronchoscopes are used at US hospitals will have little effect, as US lung specialists gave the same advice over a year ago, says Niels Granholm-Leth, Head of Equity Research at Carnegie.
by ulrich quistgaard, translated by catherine brett
On Friday, the US Food and Drug Administration (FDA) recommended that doctors at US hospitals use single-use bronchoscopes instead of reusable scopes – one year after the American Lung Association gave the same advice.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA recommends single-use bronchoscopes
For subscribers
FDA approves new Ambu product
For subscribers
.jpg)
